Navigation Links
NeurogesX to Present at JMP Securities Healthcare Focus Conference
Date:10/1/2009

mbination with other medicinal products for pain. Qutenza will be marketed in the European Union and certain countries in Eastern Europe, the Middle East and Africa, by Astellas Pharma Europe, Ltd. In the United States, NeurogesX submitted a new drug application (NDA) for PHN to the U.S. Food and Drug Administration (FDA) which was accepted for filing by the FDA in December 2008 and has been given an extended Prescription Drug User Fee Act (PDUFA) date of November 16, 2009.

NeurogesX' second most advanced product candidate, NGX-1998, is a topically applied, liquid formulation containing a high concentration of capsaicin designed to treat pain associated with neuropathic pain conditions. NGX-1998 has completed three Phase 1 studies and NeurogesX is currently planning the design and timing of this program.

NeurogesX' early stage product pipeline includes pre-clinical compounds, which are prodrugs of acetaminophen and various opioids. The company has evaluated these compounds in vitro and in vivo and is currently seeking development partners for these programs.

Safe Harbor Statement

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). NeurogesX disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include, but are not limited to the timing and outcome of regulatory decisions and label approval being sought or that may be obtained with respect to the NDA for Qutenza with the FDA, including the PDUFA date for the NDA; plans and timing for commercialization of Qutenza; and development activities for NGX-1998 and other product candidates, including regulatory submissions and any outcomes of such submissions. Such statements are based on management's current expectations, but a
'/>"/>

SOURCE NeurogesX
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
2. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
3. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
4. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
5. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
6. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
7. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
8. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
9. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
10. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
11. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 26, 2014  Thoratec Corporation (NASDAQ: ... circulatory support therapies to save, support and restore failing ... upcoming investor conferences. On Tuesday, December 2, ... Annual Piper Jaffray Healthcare Conference.  D. Keith Grossman ... update on the company beginning at 11:30 a.m., Eastern ...
(Date:11/26/2014)... 2014  Genomic Health, Inc. (Nasdaq: GHDX ) ... Executive Officer and President, will participate in the 26 ... New York Palace Hotel in New York ... Eastern Time (ET). To access the live ... to the  Investor Relations  section of the company,s web ...
(Date:11/26/2014)... , November 26, 2014 Investor-Edge ... VVUS ), Horizon Pharma PLC (NASDAQ: ... and Johnson (NYSE: JNJ ), and Theravance Inc. ... companies can be accessed at: http://investor-edge.com/register . ... 4,758.25, up 0.07%, the Dow Jones Industrial Average edged 0.02% ...
Breaking Medicine Technology:Thoratec Announces Presentations At Investor Conferences For December 2014 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
... to Receive Treatment Using Gated... -- BELLINZONA, Switzerland, Aug. 31 ... ... ... are keyed by longUrl, so we need to grab the first one. for (var r in data.results) ...
... TAINAN, Taiwan, Aug. 31 /PRNewswire-Asia/ -- ... ... var shortURL = ""; ... we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; ...
Cached Medicine Technology:Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems 2Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems 3Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems 4Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems 5Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems 6Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems 7Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems 8ScinoPharm to Invest in Tanvex Biologics 2ScinoPharm to Invest in Tanvex Biologics 3ScinoPharm to Invest in Tanvex Biologics 4ScinoPharm to Invest in Tanvex Biologics 5ScinoPharm to Invest in Tanvex Biologics 6
(Date:11/27/2014)... is making every effort to offer more affordable but ... premier online supplier of elegant special occasion dresses and ... selection of sexy prom dresses today. In addition to ... beautiful styles in its product line. Click to buy ... “VogueQueen.com hopes to provide a truly unique shopping experience ...
(Date:11/27/2014)... 2014 Dr. Ronald Receveur, who has a ... few oral health tips before patients dig into the annual ... New Albany affordable cosmetic dentistry, and his staff ... and sugar. While the staff wishes everyone a happy and ... how patients can enjoy a feast that is also healthy ...
(Date:11/27/2014)... 27, 2014 Allowing children to help with ... school, helps give children responsibility, ownership, boosts self-esteem, and above ... , Now, the real question is, how do you encourage ... According to a study published by Child Development Journal, there ... dramatic effect on a child’s willingness to lend a hand. ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Ethane Web ... has announced online reputation management service. , ... comprehensive study about the world of internet marketing and ... Yahoo. , Ethane Web Technologies does not work ... first analyzes the project to reach a conclusion what ...
(Date:11/27/2014)... November 26, 2014 Lintelus, Inc., ... platform, focused on increasing audience engagement at Convergence ... Lintelus’ software platform includes a multitude of interactive ... in a collaborative, interactive multi-screen environment. Best of ... presentation in real time on their own device. ...
Breaking Medicine News(10 mins):Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 3Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 4Health News:Ethane Web Technologies Announces Online Reputation Management Service 2Health News:Lintelus Showcases its Feature-Rich Presentation Technology Solution at Convergence Summit’s Annual Event in London 2
... PITTSBURGH, May 5 The University of Pittsburgh Cancer ... G. and Saul F. Shapira BRCA Cancer Research Program. ... mutated, dramatically increase the risk of breast, prostate, ovarian ... the addition of this research program to UPCI, said ...
... oceans play a vital role in the carbon cycle, ... enough to predict how our planet will react to ... humans are pumping into the atmosphere annually. , The ... of microscopic phytoplankton, marine plants that live in the ...
... and more with exclusive summer ... travel packages for 2008., SAN ... Kimpton Hotels & Restaurants Group announced today a,series of travel packages ... new KN Tranquility Suite(TM) offers opulent, comfort-inspired,surroundings in the heart of ...
... Attendance Doubles with More Than 175 Health Professionals From 13 ... ... ARAY ), a global leader in the field of radiosurgery, today,announced ... in,Boston, Massachusetts yielded record attendance with nearly double the,attendees over last ...
... to save a life, MINNEAPOLIS, May 5 ... the marrow Registry during the two weeks surrounding,Mother,s Day, ... campaign, kicks off today., For thousands of people ... offers a second chance at,life. Thanks Mom, which runs ...
... health status of enrollees, study says , , MONDAY, May ... insurance before enrolling in a U.S. government children,s health ... according to new research. , A waiting period ... (SCHIP), a federally funded program offering health insurance to ...
Cached Medicine News:Health News:Research program focuses on genetic mutations and cancer risk 2Health News:ESA contributes to ocean carbon cycle research 2Health News:KN Tranquility Suite(TM) Hosts Spa Indulgences and High-Tea Service on the Magnificent Mile 2Health News:KN Tranquility Suite(TM) Hosts Spa Indulgences and High-Tea Service on the Magnificent Mile 3Health News:Robotic Radiosurgery Course Yields Record Attendance 2Health News:Robotic Radiosurgery Course Yields Record Attendance 3Health News:Robotic Radiosurgery Course Yields Record Attendance 4Health News:National Marrow Donor Program(R) Kicks off National Awareness Campaign 2Health News:National Marrow Donor Program(R) Kicks off National Awareness Campaign 3Health News:Federal Health Plan for Children Still Leaves Needs Unmet 2
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Medicine Products: